Products Remdesivir is commercially available as a powder for a concentrate for the preparation of an infusion solution (Veklury, Gilead Sciences Inc, USA). Provisional approval was granted in many countries and in the EU in July 2020. On November 25, 2020, the approval will be granted. In the U.S., the drug was registered in October. … Remdesivir
Introduction Ebola is a viral infectious disease that belongs to the group of “hemorrhagic fevers” (i.e. infectious febrile diseases that cause bleeding). It occurs rarely, but in most cases it is fatal. Depending on the subtype of the virus, the mortality rate from Ebola fever is 25-90%. A causal therapy does not yet exist. The … Ebola
Where is the origin of Ebola? The Ebola virus was first detected in 1976 in what is now the Democratic Republic of Congo. The virus is named after the river Ebola, near which the first known outbreak occurred in 1976. At that time, the disease was transmitted through contaminated needles and syringes in hospitals. The … Where is the origin of Ebola? | Ebola
These symptoms may indicate Ebola The time between infection with the Ebola virus and the outbreak of the actual disease is usually about 8-10 days, but can also be 5-20 days. The Ebola fever then classically runs in two phases. The first phase is reminiscent of a flu-like infection. Patients initially develop fever, chills, headache … These symptoms may indicate Ebola | Ebola
Diagnostics In order to prove an infection with the Ebola virus beyond doubt, it is not sufficient to assess the clinical condition of the patient, as the presentation may be very similar to infections with other hemorrhagic viruses. To confirm the diagnosis, body secretion of the sick patient is needed, for example saliva, urine or … Diagnostics | Ebola